Results 51 to 60 of about 118,029,410 (206)

Ductal Carcinoma in situ of the female Breast [PDF]

, 2007
The breast is the most common site of cancer in females in many parts of the world. Mammary carcinoma is either ductal arising from ducts or lobular arising from lobules.
Mohammadani, A.A., Mohamed, Elgaili, Elkhatim, Mukhtar   +2 more
core  

Tamoxifen Initiation After Ductal Carcinoma In Situ [PDF]

, 2016
Endocrine therapy initiation after ductal carcinoma in situ (DCIS) is highly variable and largely unexplained. National guidelines recommend considering tamoxifen for women with estrogen receptor-positive (ER+) DCIS or who undergo excision alone.
Bowles, Erin J. A., Buist, Diana S. M., Nichols, Hazel B., Islam, Jessica, Stürmer, Til, Tran, Diem-Thy, Madziwa, Lawrence   +6 more
core   +1 more source

Supplementary Figure S5 from Whole-Exome Sequencing Analysis of the Progression from Non–Low-Grade Ductal Carcinoma In Situ to Invasive Ductal Carcinoma

, 2020
Supplementary Figure S5 shows BRCA1 loss of heterozygosity in the different foci of synchronously diagnosed ductal carcinoma in situ and invasive ductal carcinoma of no special type in a BRCA1 germline carrier.
David N. Brown (6742649), Edaise M. da Silva (14937768), Britta Weigelt (40755), Fresia Pareja (677937), Mahsa Vahdatinia (15022077), Andrea Gazzo (15022074), Rui Bi (196341), Felipe C. Geyer (8769284), Ju Youn Lee (6742645), Jorge S. Reis-Filho (6742726), Hannah Y. Wen (6742657), Lorenzo Ferrando (15022083), James B. Hicks (15022086), Anthe A. Stylianou (15022080), Arnaud Da Cruz Paula (8097278), Pier Selenica (6742648)   +15 more
core   +1 more source

Carcinoma ductal in situ arising in a fibroadenoma: report of a rare case

Revista Médica de Minas Gerais, 2021
Although fibroadenoma is one of the most common lesions of the breast, its correlation with malignant changes is rare. When it occurs, the clinical presentation is similar to typical fibroadenomas, anatomopathological diagnosis is after surgery and ...
Jácome, Anna Carolina Pereira, Pinto, Bárbara Mendes, Mourão, Érika Monteiro Pinheiro, Beraldo, Fábia Silveira, Santos, Luís Cláudio   +4 more
doaj   +1 more source

Consultoria em patologia cirúrgica mamária: variabilidade interobservador no diagnóstico de lesões proliferativas intraductais atípicas Consultation in breast surgical pathology: interobserver diagnostic variability of atypical intraductal proliferative lesions

Revista Brasileira de Ginecologia e Obstetrícia, 2013
OBJETIVO: Avaliar a concordância nos diagnósticos histopatológicos de lesões mamárias proliferativas intraductais entre patologistas gerais e especialistas em patologia mamária.
Amanda Arantes Perez, Débora Balabram, Marcio de Almeida Salles, Helenice Gobbi   +3 more
doaj  

Grading and Study of Biological Markers in Ductal Carcinoma in situ and Concurrent Infiltrating Ductal Carcinoma of Breast [PDF]

Journal of Clinical and Diagnostic Research, 2018
Introduction: Breast cancer is the most common cancer in women. Breast cancer has surpassed cervical cancer and is now the leading cause of cancer death; however, cervical cancer still remains common in rural areas.
Lovely George, Muktha Ramesh Pai
doaj   +1 more source

Ductal carcinoma in situ of the breast: immune cell composition according to subtype.

, 2020
Ductal carcinoma in situ of the breast includes several subtypes with a divergent biological behavior. Data regarding the composition of ductal carcinoma in situ-associated immune cells and their potential role in progression is limited.
Agahozo, Marie, Van Bockstal, Mieke, Agahozo, Marie Colombe, van den Bosch, Thierry; id_orcid, van Deurzen, Carolien, Groenendijk, Floris, Westenend, Pieter J, Groenendijk, Floris H, Westenend, PJ, van den Bosch, Thierry P P, van Deurzen, Carolien H M, Bockstal, Mieke   +11 more
core   +1 more source

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

, 2003
BACKGROUND: As a consequence of mammographic breast screening programmes, ductal carcinoma in situ is diagnosed with increasing frequency. Mastectomy for localised ductal carcinoma in situ is thought to be an over-treatment by many physicians, but there ...
Duggan, Catherine, Spittle, Margaret, Houghton, J, ?, ?, Houghton, Joan, Cuzick, Jack, Fentiman, Ian S, DCIS trialists in the UK, Australia, and New Zealand, Ductal Carcinoma in situ Working Party, Fentiman, I S, George, WD, UK Coordinating Committee on Cancer Research   +11 more
core   +1 more source

Basal cytokeratin as a potential marker of low risk of invasion in ductal carcinoma in situ

Clinics, 2013
OBJECTIVES: Biological markers that predict the development of invasive breast cancer are needed to improve personalized therapy for patients diagnosed with ductal carcinoma in situ.
Fernando N. Aguiar, Henrique N. Mendes, Cinthya S. Cirqueira, Carlos E. Bacchi, Filomena M. Carvalho   +4 more
doaj  

Carcinoma In Situ Involving Sclerosing Adenosis on Core Biopsy: Diagnostic Pearls to Aid the Practicing Clinician and Avoid Overtreatment

Oncology and Therapy, 2020
Introduction Involvement of pre-existing benign lesions by ductal carcinoma in situ (DCIS) or lobular neoplasia (LN) can present difficult diagnostic challenges, and can easily cause misdiagnosis of invasive carcinoma and over-management of localized ...
Dana Richards, Alberto A. Ayala, Yun Wu, Lavinia P. Middleton   +3 more
doaj   +1 more source